Publications:

Ephrin-B1 Is a Novel Biomarker of Bladder Cancer Aggressiveness. Studies in Murine Models and in Human Samples.

Frontiers In Oncology

Mencucci, María Victoria MV; Lapyckyj, Lara L; Rosso, Marina M; Besso, María José MJ; Belgorosky, Denise D; Isola, Mariana M; Vanzulli, Silvia S; Lodillinsky, Catalina C; Eiján, Ana María AM; Tejerizo, Juan Carlos JC; Gonzalez, Matías Ignacio MI; Zubieta, María Ercilia ME; Vazquez-Levin, Mónica Hebe MH

Publication Date: 2020

Variant appearance in text: CDH1: 628G>C; E210Q

PubMed Link: 32292715

Variant Present in the following documents:

• Main text
• fonc-10-00283.pdf

View BVdb publication page

Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA genomic profiling.

Molecular Genetics & Genomic Medicine

Chen, Zhanhong Z; Sun, Tian T; Yang, Ziyan Z; Zheng, Yabing Y; Yu, Ruoying R; Wu, Xue X; Yan, Junrong J; Shao, Yang W YW; Shao, Xiying X; Cao, Wenming W; Wang, Xiaojia X

Publication Date: 2020-02

Variant appearance in text: CDH1: 628G>C; E210Q

PubMed Link: 31867841

Variant Present in the following documents:

• MGG3-8-e1079-s004.xlsx, sheet 1

View BVdb publication page

Cyclin A2 mutagenesis analysis: a new insight into CDK activation and cellular localization requirements.

Plos One

Bendris, Nawal N; Lemmers, Bénédicte B; Blanchard, Jean-Marie JM; Arsic, Nikola N

Publication Date: 2011

Variant appearance in text: CDH1: E210Q

PubMed Link: 21829545

Variant Present in the following documents:

• Main text
• pone.0022879.pdf

View BVdb publication page